102 related articles for article (PubMed ID: 8458376)
1. In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants.
Nussler AK; Rénia L; Pasquetto V; Miltgen F; Matile H; Mazier D
Eur J Immunol; 1993 Apr; 23(4):882-7. PubMed ID: 8458376
[TBL] [Abstract][Full Text] [Related]
2. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
3. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites.
Klotz FW; Scheller LF; Seguin MC; Kumar N; Marletta MA; Green SJ; Azad AF
J Immunol; 1995 Apr; 154(7):3391-5. PubMed ID: 7534796
[TBL] [Abstract][Full Text] [Related]
4. T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes.
Hoffman SL; Isenbarger D; Long GW; Sedegah M; Szarfman A; Mellouk S; Ballou WR
Bull World Health Organ; 1990; 68 Suppl(Suppl):132-7. PubMed ID: 2151270
[TBL] [Abstract][Full Text] [Related]
5. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
6. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
[TBL] [Abstract][Full Text] [Related]
8. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
9. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
Meraldi V; Romero JF; Kensil C; Corradin G
Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stages of malaria: specific and non-specific factors inhibiting the development.
Mazier D; Rénia L; Pied S; Nussler A; Marussig M; Landau I; Miltgen F; Grillot D; Del Giudice G; Grau G
Parassitologia; 1993 Jul; 35 Suppl():59-63. PubMed ID: 8233615
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium berghei: production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice.
Scheller LF; Stump KC; Azad AF
J Parasitol; 1995 Feb; 81(1):58-62. PubMed ID: 7876979
[TBL] [Abstract][Full Text] [Related]
12. Rodent malaria: BCG-induced protection and immunosuppression.
Smrkovski LL; Strickland GT
J Immunol; 1978 Oct; 121(4):1257-61. PubMed ID: 100553
[TBL] [Abstract][Full Text] [Related]
13. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
14. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
Vanderberg JP; Khan ZM; Stewart MJ
J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
[TBL] [Abstract][Full Text] [Related]
15. Development of antimalaria immunity in mice lacking IFN-gamma receptor.
Tsuji M; Miyahira Y; Nussenzweig RS; Aguet M; Reichel M; Zavala F
J Immunol; 1995 May; 154(10):5338-44. PubMed ID: 7537305
[TBL] [Abstract][Full Text] [Related]
16. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
17. Sneaking in through the back entrance: the biology of malaria liver stages.
Frevert U
Trends Parasitol; 2004 Sep; 20(9):417-24. PubMed ID: 15324732
[TBL] [Abstract][Full Text] [Related]
18. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte.
Ishino T; Chinzei Y; Yuda M
Mol Microbiol; 2005 Dec; 58(5):1264-75. PubMed ID: 16313615
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells.
Ojo-Amaize EA; Vilcek J; Cochrane AH; Nussenzweig RS
J Immunol; 1984 Aug; 133(2):1005-9. PubMed ID: 6429240
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of immunity to Plasmodium yoelii sporozoites.
Weiss WR; Good MF; Hollingdale MR; Miller LH; Berzofsky JA
J Immunol; 1989 Dec; 143(12):4263-6. PubMed ID: 2512354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
